Single combination pill provides benefit to patients with or at risk of CVD
In a randomized trial that included about 2,000 patients with or at high risk of cardiovascular disease (CVD), use of a fixed-dose combination medication for blood pressure, cholesterol, and platelet control compared to usual care resulted in significantly improved medication adherence after 15 months and small improvements in systolic blood pressure and low-density lipoprotein cholesterol, according to a study in the September 4 issue of JAMA.
"The long-term use of cardiovascular disease preventive therapy is low among people with established disease. This shortfall ...